Atlas Trials

Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients

Clinical trial NCT06019676 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06019676
Sponsor
Royal Marsden NHS Foundation Trust
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Start date
2023-09-26
Primary completion
2027-04-01
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.